COGNITION THERAPEUTICS INC (CGTX) Executive Compensation
COGNITION THERAPEUTICS INC (CGTX) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CGTX
CIK: 1455365
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerRyan Murray
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-07 | 2026-06-30 | 10-Q | 0001104659-26-092362 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | FORM 8-K | 0001104659-26-092037 | View SEC Doc Filr Page |
| 8-K | 2026-06-24 | 2026-06-24 | FORM 8-K | 0001104659-26-077060 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | OWNERSHIP DOCUMENT | 0001104659-26-076477 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | OWNERSHIP DOCUMENT | 0001104659-26-076475 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | OWNERSHIP DOCUMENT | 0001104659-26-076472 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | OWNERSHIP DOCUMENT | 0001104659-26-076470 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | PRIMARY DOCUMENT | 0001789490-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-17 | FORM 8-K | 0001104659-26-075442 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-06-04 | FORM 8-K | 0001104659-26-070345 | View SEC Doc Filr Page |
| 8-K | 2026-05-21 | 2026-05-21 | FORM 8-K | 0001104659-26-064863 | View SEC Doc Filr Page |
| 10-Q | 2026-05-08 | 2026-03-31 | 10-Q | 0001104659-26-057545 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | FORM 8-K | 0001104659-26-057186 | View SEC Doc Filr Page |
| 4 | 2026-05-04 | 2026-05-01 | OWNERSHIP DOCUMENT | 0001104659-26-054858 | View SEC Doc Filr Page |
| ARS | 2026-04-27 | 2025-12-31 | ARS | 0001104659-26-049438 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-27 | — | DEFA14A | 0001104659-26-049436 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-27 | 2026-06-17 | DEF 14A | 0001104659-26-049427 | View SEC Doc Filr Page |
| 4 | 2026-04-20 | 2026-04-16 | OWNERSHIP DOCUMENT | 0001104659-26-045511 | View SEC Doc Filr Page |
| 4 | 2026-04-20 | 2026-04-16 | OWNERSHIP DOCUMENT | 0001104659-26-045502 | View SEC Doc Filr Page |
| 4 | 2026-04-20 | 2026-04-16 | OWNERSHIP DOCUMENT | 0001104659-26-045499 | View SEC Doc Filr Page |
| S-8 | 2026-03-26 | — | FORM S-8 | 0001104659-26-034887 | View SEC Doc Filr Page |
| 10-K | 2026-03-26 | 2025-12-31 | 10-K | 0001104659-26-034880 | View SEC Doc Filr Page |
| 8-K | 2026-03-26 | 2026-03-26 | FORM 8-K | 0001104659-26-034876 | View SEC Doc Filr Page |
| 8-K | 2026-03-02 | 2026-03-02 | FORM 8-K | 0001104659-26-021904 | View SEC Doc Filr Page |
| 4 | 2026-02-18 | 2026-02-15 | OWNERSHIP DOCUMENT | 0001104659-26-017070 | View SEC Doc Filr Page |